Despite the impact of the ongoing COVID-19 pandemic, the Asia Pacific urological device market will continue to expand through 2029 due to growing patient awareness of urological treatments in this region. In particular, rising use of minimally invasive laser treatments in China and India, where these techniques have been underpenetrated, will result in increased adoption of associated devices. However, the market will be negatively affected in the short term by the global COVID-19 pandemic.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for urological devices in Asia Pacific across a 10-year period.
The COVID-19 pandemic will negatively impact the Asia Pacific urological device market.
Which types of procedures and device segments will be most impacted?
At what pace is the urological device market expected to recover?
Some market segments are being negatively impacted by product safety concerns.
Which market segments are being impacted by safety concerns?
In which countries are these markets highly affected by these concerns, and in which countries are these markets less affected?
Minimally invasive treatment volumes will significantly increase over the forecast period in the Asia Pacific urological device market.
What factors are contributing to the increasing use of minimally invasive treatments?
Which market segments will see the greatest adoption of minimally invasive treatments?
The rising adoption of flexible endoscopy in this market will spur growth in multiple device segments.
How many flexible cystoscopes and flexible ureteroscopes will be sold in this region?
How will the stone management device market be impacted by growth in flexible endoscope use?
Will any markets be negatively impacted by the growing use of flexible endoscopy?
- Urological Devices - Market Insights - Asia Pacific
Author(s): Sumit Jain, MS Pharm
Sumit Jain is an analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, focusing on diagnostic imaging capital equipment and healthcare IT markets. Sumit holds a Bachelor's degree in Pharmacy from the Rajiv Gandhi Technical University, Bhopal, and a Master's degree in Pharmacoinformatics from the National Institute of Pharmaceutical Education and Research, Mohali.